About Authors:
1Bhatt Mehul K.*, 2Dr. Captain A.D.
1Department of Pharmacognosy,
Shivam Pharmaceutical Studies & Research Centre,
Valasan-388 326, Anand, Gujarat, India.
2Department of Pharmaceutical chemistry
A. R. College and G. H Patel institute of Pharmacy,
Vallabh Vidyanagar, Anand-380 015, Gujarat, India.
*mkb_0999@yahoo.co.in
Absract:
Today estimate that about 80% of people in developing countries still relays on traditional medicine based largely on species of plants and animals for their primary health care. India has one of the richest plant traditions in the world. These are estimated to by around 25,000 effect plant based formulations, used in folk medicine and known to rural communities in India. India’s share in the export of herbals is USD 63 billion which is just 0.2% of the global herbal market. So there is obviously vast scope for Indian manufacturers for entering the growing worldwide opportunity of business in herbal pharmaceutical field. We also have to focus on standardization of herbal products. Pharmaceutical export promotion council i.e PHARMEXCIL is ready to play a key role in this regards. Currently, a majority of the adverse events related to the use of herbal products and herbal medicines that are reported are attributable either to poor product quality or to improper use. Inadequate regulatory measures, weak quality control systems and largely uncontrolled distribution channels may have been contribution to the occurrence of such events. So Pharmacovigilance of herbal medicines is required.
.png)
